While GLP-1 medications like Ozempic and Wegovy hold promise for both weight loss and diabetes management, their potential for accidental misuse requires caution
Phase 3 Current trial stage 2027 to 2028 Projected approval window 28.7% TRIUMPH-4 weight loss at 68 wks No NDA Filed as of May 2026 What Is Retatrutide's Current FDA Status
However, with the aspects of these new mass obesity medications, the microenvironment, the genetic environment, and lifestyle and behavior change is especially difficult for these patients to lose weight and maintain it, and we also know that, from SURMOUNT trials and some real-world evidence, that tirzepatide is extremely effective at encouraging significant weight loss. Huang and colleagues conducted a retrospective cohort study of 4,241 women living with PCOS (median age, 34 years
The ideal concentration of GHK-Cu for skin benefits ranges from 0.05% to 0.5% , depending on your skin type and goals
In this section, well break down the key differences between sublingual and injectable semaglutide, making it easy to understand how each form is unique
Their effects on bowel transit lower in the gut appear more variable and may differ between individuals and medications